三诺生物：持续葡萄糖监测系统获欧盟MDR认证

Core Insights - The company, Sanofi Biologics, has announced that its self-developed "Continuous Glucose Monitoring System" has received EU Medical Devices Regulation (MDR) certification [1] - This system is designed to measure glucose levels in interstitial fluid for individuals aged 2 and above, aiming to replace traditional fingertip blood glucose tests for diabetes treatment decisions [1] - The second-generation CGM product features an integrated design that enhances user convenience and comfort while maintaining core technology [1] - The recent approval expands the applicable scenarios for both generations of the company's CGM products [1]